Lectures and seminars
Medicine Safety, Rational Cost-Effective Treatment, Personalised Medicines
Pfizer Pharmacogenomics 9.04
UHCW Grand Round 2004
Warwick Hospital Grand Round 2004
Centre for Ethics, University of Reykjavik, Iceland 1.05
George Elliot NHS Trust Research Study Day 9.05
MHRA 10.05
UHCW Grand Round 20.10.05
International Genes to Patients Personalised Medicines Symposium, University of Warwick 5.7.06
Warwick Hospital SpR Training 7.9.06
Pharmacogenomics International Worskhop, Reykjavik 11.06
Royal Society of Chemistry Series, University of Wolverhampton 12.06
Microcirculation
London Hypertension Society 17.3.05
British Pharmacology Society Signalling Symposium, Leicester 4.05
British Pharmacology Society Meeting, Cambridge 7.05
Department of Cardiology, Graduate Schoool of Medicine, Nagoya, Japan 7.05
Endocrine-Hypertension Division Tokyo Medical and Dental University, Japan 7.05
Microcirculation Society, Durham, New Hampshire USA 9.05
Oxidant stress and vascular function. London Hypertension Society 11.10.05
British Pharmacology Society, London 22.12.05
Microvasculature and oxidant stress. MOAC Centre, University of Warwick, 24.6.06
VEGF and angiogenic signalling. World Congress of Cardiology/European Society of Cardiology. Barcelona, 3.9.06
Angiotensin II Gordon Conference, Aussois, France 10.9.06
Microvasculature and cardiovascular risk. Computer Science, University of Warwick, October 2006
Angiogenesis symposium, Nagoya University, 5.12.06
siRNA as new therapeutic agents. British Pharmacology Society, Brighton, 2007.
Angiotensin II Gordon Research Conference. Ventura, USA, February 2008.
Microvasculature and cardiovascular risk. Angiological Days 2008. Prague, March 2008.
Managing hypertension in patients with peripheral artery disease. Angiological Days 2009. Prague, 26th-28th February, 2009
Blood Pressure & Cardiovascular risk
American Society of Hypertension, San Francisco 5.05
European Society of Cardiology, Stockholm 9.05
New biomarkers of Cardiovascular risk, UHCW 4.06
New biomarkers of Cardiovascular risk, Coventry, 5.06
Blood pressure and telecare, Coventry 2.11.06
Virtual health, Rugby 9.01.07
How to reduce risk after stroke. British Hypertension Society Masterclass on Hypertension & Cerebrovascular disease, Leicester 13.2.07
Update on blood pressure and telecare, Coventry 24.02.07
Preventing cardiovacular risk in diabetes, PACE, Birmingham 8.3.07
BHS/NICE guidelines:rationale for targeting the renin-angiotensin system, Coventry 27.3.07
Feasibility study of a virtual approach to cardiovascular management. West Midlands Physicians' Association. November 2007.
Metabolic effects on vascular function. British Hypertension Society Masterclass on Cardio-metabolic aspects of Hypertension. University of Warwick, March, 2007.
E-Health and blood pressure management. London Hypertension Society, April 2008.
Lower blood pressure to prevent atherosclerosis: stiffness - the holy grail? 5th Hungarian Conference on Arterial Stiffness. Budapest, Feb 20th-21st, 2009.
